[{"id":"f8623cc4-62f7-4b2d-92a3-b96307060fe0","acronym":"CARMA-01","url":"https://clinicaltrials.gov/study/NCT06002659","created_at":"2023-08-21T14:08:59.477Z","updated_at":"2024-07-02T16:35:04.590Z","phase":"Phase 1/2","brief_title":"CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study)","source_id_and_acronym":"NCT06002659 - CARMA-01","lead_sponsor":"Uppsala University","biomarkers":" CD20","pipe":"","alterations":" ","tags":["CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • ELC-301"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 05/01/2024","start_date":" 05/01/2024","primary_txt":" Primary completion: 12/30/2027","primary_completion_date":" 12/30/2027","study_txt":" Completion: 12/30/2027","study_completion_date":" 12/30/2027","last_update_posted":"2024-05-09"}]